The Impact of glutamine suppletion on outcome in patients undergoing high-risk cardiothoracic surgery.
Phase 4
Completed
- Conditions
- heart-failure100192801001981510007593
- Registration Number
- NL-OMON29879
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Patients with a left ventricular ejection fraction <35%;Patients screened by the Mission! Heart Failure Program and scheduled for one of the surgical interventions in this program.
Exclusion Criteria
Emergency operations
Renal impairment (creatinine clearance <25 mL/min)
Pregnancy
<18 Years old
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary Outcome<br /><br><br /><br>* Infectious complications in the ICU and in the hospital</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary Outcomes<br /><br><br /><br>* Cardiac morbidity in the ICU and in the hospital<br /><br>* Pulmonary morbidity in the ICU and in the hospital<br /><br>* Gastro-intestinal morbidity in the ICU and the hospital.<br /><br>* ICU mortality<br /><br>* In-hospital mortality<br /><br>* Length of ICU stay<br /><br>* Length of hospital stay<br /><br>* Impact on immune function</p><br>